NeuroStar-related presentations at CTMSS reflect the Company’s commitment to advancing TMS research and learning from real-world evidence. The Company continues to explore treatment outcomes across ...
Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial Magnetic Stimulation (TMS) Trial is planned to ...
Serenity Mental Health Centers, a behavioral health provider specializing in evidence-based treatment for depression, anxiety, PTSD and other mental disorders, today announced the opening of its ...
Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to the delivery of Transcranial ...
10d
Innovative, Life Changing TMS Therapy at Northeast Health Services’ Boston Government Center Clinic
Northeast Health Services now offers NeuroStar TMS therapy in Boston, providing an innovative, non-drug treatment for ...
China: A randomized clinical trial has found that an ultra-brief intermittent theta-burst stimulation (iTBS) protocol can ...
A peer-reviewed case study published in the journal Transcranial Magnetic Stimulation reports that an accelerated ...
ALPHARETTA, GA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- MagVenture®, a global leader in non-invasive ...
A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.
A patient with treatment-resistant depression (TRD) costs Medicare 21%, or $8,000, more annually than a patient with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results